A Randomized, Controlled Trial of Cognitive-Behavioral Therapy for Augmenting Pharmacotherapy in Obsessive-Compulsive Disorder

OBJECTIVE: Although serotonin reuptake inhibitors (SRIs) are approved for the treatment of obsessive-compulsive disorder (OCD), most OCD patients who have received an adequate SRI trial continue to have clinically significant OCD symptoms. The purpose of this study was to examine the effects of augm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Simpson, Helen Blair, Foa, Edna B., Liebowitz, Michael R., Ledley, Deborah Roth, Huppert, Jonathan D., Cahill, Shawn, Vermes, Donna, Schmidt, Andrew B., Hembree, Elizabeth, Franklin, Martin, Campeas, Raphael, Hahn, Chang-Gyu, Petkova, Eva
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3945728/
https://ncbi.nlm.nih.gov/pubmed/18316422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.ajp.2007.07091440
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados